Evaluating and managing "Triple Negative" MPN

Earn CME for related activities: www.naccme.com/oln
In this presentation from the Great Debates & Updates in Hematologic Malignancies 2018 conference, Dr. Ruben A. Mesa discusses challenges in the evaluation and management of 'triple negative' myeloproliferative neoplasms (MPN).
© 2018 Imedex, LLC.

[@jeanwarech6428]

I have triple negative ET.

[@insertname5421]

check your JAK2 46/1 haplotype

[@JacCee710]

Me too

[@curiousturtle8190]

@@JacCee710 How are you doing? How are your symptoms and are you on some medication already?

[@BLTwithMayo1]

I've recently been diagnosed with T-N ET.